ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Incidence of clinically diagnosed infections in children with sickle cell anaemia treated with oral hydroxyurea in Angola, DR Congo, Kenya, and Uganda: a retrospective cohort study from the REACH trial

Study limitation reported by the research below: “The single-arm design means that observed declines in infection rates over time could partly reflect natural disease course, regression to the mean, or improved clinical familiarity rather than a hydroxyurea effect.”

Papers